EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma: A Systematic Review and Meta-Analysis of Prospective Trials

K Liang Zeng, Alexander V Louie, Rupesh Kotecha, Arjun Sahgal, Zhenwei Zhang, Lili Zhou, Thierry Gevaert, Matthias Guckenberger, Mi-Sook Kim, Simon Lo, Marta Scorsetti, Ben Slotman und 2 weitere

Practical Radiation Oncology · 2026-11 · 16 (6) · 626-641

DOI: 10.1016/j.prro.2026.04.015 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Practical Radiation Oncology, 2026-11. Verfasst von K Liang Zeng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Radiosurgery, Pancreatic Neoplasms, Adenocarcinoma. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Royal Marsden NHS Foundation Trust, Cancer Research UK, National Institute on Handicapped Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Modern technology has facilitated dose-escalated stereotactic body radiation therapy (SBRT) through real-time soft-tissue delineation and adaptive radiation therapy for locally advanced/unresectable pancreatic cancer (LAPC). The current study examined published prospective trials in SBRT for LAPC to inform clinical decision-making with support from the International Stereotactic Radiosurgery Society. METHODS AND MATERIALS: A systematic review and meta-analysis was conducted of all prospective trials in definitive SBRT (up to 6 fractions) for LAPC. Random-effects meta-analysis was performed, and metaregression was used to assess the effect of covariates on outcomes of interest, including local control (LC), progression-free survival (PFS), overall survival (OS), and toxicities. RESULTS: A total of 23 prospective studies were identified, including 901 patients. Most studies (n = 21, 91.3%) used systemic therapy before SBRT and delivered a median dose of 40 Gy in 5 fractions (range, 24-50 Gy in 3-6 fractions). The pooled 12- and 24-month LC estimate was 82% and 70%, respectively; 12-month PFS and OS rates were 35% and 63%, respectively; and 24-month PFS and OS rates were 15% and 28%, respectively. On univariable metaregression, SBRT with ≥5 fractions was associated with improved 12-month LC and OS. Inclusion of an elective clinical target volume was associated with improved 24-month PFS and OS. A higher biologically effective dose (BED10) was associated with improved 24-month LC and OS. Surgery was associated with improved 12- and 24-month OS and 12-month PFS. The pooled estimate for risk of any grade 3-4 toxicities was 2%, and that of grade 5 toxicities was 0.2% (7 events), mostly gastrointestinal bleeding. There were no predictors of grade 3-4 or 5 toxicities. CONCLUSIONS: Modern radiation therapy techniques allow safe delivery of high radiation doses for LAPC. SBRT provides excellent and durable LC with low rates of treatment-related grades ≥3 toxicities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryPancreatic NeoplasmsAdenocarcinomaHumansProspective Studies

Autor:innen und Institutionen

  • Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada.
  • Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida; Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
  • T&D - Artificial Intelligence, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
  • Department of Radiotherapy, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Belgium.
  • Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.

Förderung

  • Royal Marsden NHS Foundation Trust
  • Cancer Research UK
  • National Institute on Handicapped Research
  • Institute of Cancer Research

Zitieren

APA

Zeng, K. L., Louie, A. V., Kotecha, R., Sahgal, A., Zhang, Z., Zhou, L., Gevaert, T., Guckenberger, M., Kim, M. S., Lo, S., Scorsetti, M., Slotman, B., Tree, A., & Ng, S. S. W. (2026). Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma: A Systematic Review and Meta-Analysis of Prospective Trials. Practical Radiation Oncology, 16(6), 626-641. https://doi.org/10.1016/j.prro.2026.04.015

Vancouver

Zeng KL, Louie AV, Kotecha R, Sahgal A, Zhang Z, Zhou L, et al. Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma: A Systematic Review and Meta-Analysis of Prospective Trials. Practical Radiation Oncology. 2026;16(6):626-641. doi:10.1016/j.prro.2026.04.015

BibTeX
@article{Zeng2026,
  author = {Zeng, K Liang and Louie, Alexander V and Kotecha, Rupesh and Sahgal, Arjun and Zhang, Zhenwei and Zhou, Lili and Gevaert, Thierry and Guckenberger, Matthias and Kim, Mi-Sook and Lo, Simon and Scorsetti, Marta and Slotman, Ben and Tree, Alison and Ng, Sylvia S W},
  title = {Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma: A Systematic Review and Meta-Analysis of Prospective Trials},
  journal = {Practical Radiation Oncology},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {626--641},
  doi = {10.1016/j.prro.2026.04.015}
}
Kostenlos starten →